Enterome
OtherEnterome raised €16M in a funding round in Jun 2025. The company is based in Paris, France. Investors in the round: existing specialist investors, The Institute for Follicular Lymphoma Innovation (IFLI), The Leukemia & Lymphoma Society Therapy Acceleration Program® (LLS TAP). Data as of Nov 2026.
Amount raised
€16M
€16,387,787
Native amount
19,000,000 USD
Stage
Other
funding round
Investors
3
Provenance & confidence
High confidenceAmount
19,000,000 USD
ECB-at-date → €16M · rate 1.1594 on 2025-06-12
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
3 namedexisting specialist investorsThe Institute for Follicular Lymphoma Innovation (IFLI)The Leukemia & Lymphoma Society Therapy Acceleration Program® (LLS TAP)
Date
Jun 2025
Round type
funding round
Amount (EUR)
€16M